Correlation Between Berkshire Hathaway and Medicus Pharma

Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and Medicus Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and Medicus Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Berkshire Hathaway CDR and Medicus Pharma, you can compare the effects of market volatilities on Berkshire Hathaway and Medicus Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of Medicus Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and Medicus Pharma.

Diversification Opportunities for Berkshire Hathaway and Medicus Pharma

-0.46

Correlation Coefficient

Berkshire Hathaway  Medicus Pharma

Very good diversification

The 3 months correlation between Berkshire and Medicus is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway CDR and Medicus Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicus Pharma and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway CDR are associated (or correlated) with Medicus Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicus Pharma has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and Medicus Pharma go up and down completely randomly.

Pair Corralation between Berkshire Hathaway and Medicus Pharma

Assuming the 90 days trading horizon Berkshire Hathaway is expected to generate 48.23 times less return on investment than Medicus Pharma. But when comparing it to its historical volatility, Berkshire Hathaway CDR is 14.29 times less risky than Medicus Pharma. It trades about 0.02 of its potential returns per unit of risk. Medicus Pharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  434.00  in Medicus Pharma on September 15, 2024 and sell it today you would lose (39.00) from holding Medicus Pharma or give up 8.99% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Berkshire Hathaway CDR  vs.  Medicus Pharma

Berkshire Hathaway CDR

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Berkshire Hathaway CDR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Berkshire Hathaway is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Medicus Pharma

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Medicus Pharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Medicus Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Berkshire Hathaway and Medicus Pharma

The main advantage of trading using opposite Berkshire Hathaway and Medicus Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, Medicus Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicus Pharma will offset losses from the drop in Medicus Pharma's long position.

The idea behind Berkshire Hathaway CDR and Medicus Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.